Free radicals: a potential pathogenic mechanism in inherited muscular dystrophy

Life Sciences
|December 15, 1986
PubMed

Insights

Free radicals may cause inherited muscular dystrophy by damaging muscle cells. This oxidative stress hypothesis explains cellular issues and antioxidant system changes seen in the disease.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Genetics

Background:

  • The precise biochemical defect underlying inherited muscular dystrophy remains elusive in both human and animal models.
  • Cellular abnormalities observed in dystrophic muscles suggest potential damage mechanisms.
  • Oxidative stress and antioxidant system responses are implicated in various cellular pathologies.

Purpose of the Study:

  • To review and evaluate the evidence supporting the free radical hypothesis for muscular dystrophy pathogenesis.
  • To explore how free radical damage could explain observed cellular and biochemical abnormalities in dystrophic muscle.
  • To assess the consistency of the free radical hypothesis with existing data and alternative theories.

Main Methods:

  • Literature review of studies on muscular dystrophy, free radicals, and antioxidant systems.
  • Analysis of cellular and biochemical data from dystrophic muscle tissues (human and animal).
  • Examination of enzymatic antioxidant responses in dystrophic models.

Main Results:

  • Cellular abnormalities in dystrophic muscles are consistent with free radical-mediated damage.
  • Chemical markers of free radical damage are present in dystrophic muscle tissue.
  • Enhanced antioxidant systems are observed in dystrophic muscle cells and other tissues, indicating a response to oxidative stress.
  • Deficiencies in antioxidant systems (e.g., vitamin E) or increased free radical production could explain increased damage.

Conclusions:

  • The free radical hypothesis provides a unifying explanation for various observations in muscular dystrophy.
  • This hypothesis accounts for data supporting alternative theories and previously unexplained findings.
  • Further research into oxidative stress mechanisms is warranted for understanding and potentially treating muscular dystrophy.

Related Concept Videos

Mutations01:39

Mutations

Overview
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...